Optimising the Detection and Management of Familial Hypercholesterolaemia: Central Role of Primary Care and its Integration with Specialist Services

• Published in: Heart, lung & circulation Vol. 23; no. 12; pp. 1158 - 1164
• Main Authors: Vickery, Alistair W., FRACGP, Bell, Damon, FRACP, FRCPA, Garton-Smith, Jacquie, FRACGP, Kirke, Andrew B., FRACGP, Pang, Jing, PhD, Watts, Gerald F., DSc, MD, PhD, FRACP
• Format: Journal Article
• Language: English
• Published: Australia Elsevier B.V 01.12.2014
• Subjects: Algorithms; Cardiovascular; Cardiovascular diseases; Cholesterol, LDL - blood; Education, Medical, Continuing; Familial hypercholesterolaemia; Female; General Practitioners; Genetic predisposition to disease; Genetic Testing; Humans; Hyperlipoproteinemia Type II - blood; Hyperlipoproteinemia Type II - diagnosis; Hyperlipoproteinemia Type II - genetics; Hyperlipoproteinemia Type II - therapy; Male; Mass screening; Primary Health Care; Genetic predisposition to disease; Cardiovascular diseases; Primary health care; Mass screening; Familial hypercholesterolaemia

Familial hypercholesterolaemia (FH) is the most common monogenic lipid disorder associated with premature coronary heart disease (CHD). However, the majority of people with FH are undiagnosed or undertreated. Early cholesterol lowering therapy reduces cardiovascular disease mortality in FH. Low awar...